Detalhe da pesquisa
1.
Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.
Ann Rheum Dis
; 73(5): 909-12, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24385201
2.
Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
Arthritis Rheum
; 57(3): 448-53, 2007 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17394231
3.
Influences that drive clinical decision making among junior rheumatology nurses: a qualitative study.
Musculoskeletal Care
; 4(4): 223-32, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17117446
4.
Influences that drive clinical decision-making among rheumatology nurses. Part 1: literature review.
Musculoskeletal Care
; 4(3): 130-9, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17042024
5.
C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.
Arthritis Rheum
; 52(1): 42-8, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15641046
6.
Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis.
Arthritis Rheum
; 57(8): 1564-7, 2007 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18050231